Novo Nordisk recently made headlines petitioning FDA to stop the compounding of its blockbuster GLP-1 products so it can sell its patented semaglutide drugs exclusively. Compounding is the practice of ...
Ensuring clinically sound, cost-effective medication therapy is a critical function of pharmacists. Yet addressing the costly and potentially dangerous process of sterile IV compounding—one of the ...
What motivated the shift into the veterinary space? Topelius: Actually, we started with veterinary applications. When we founded the company, our first application areas w ...
In early 2024, the American Society of Health-System Pharmacists (ASHP) reported a record 323 active drug shortages, many affecting sterile injectable medications. This situation was exacerbated later ...
Increasing competition and decreasing reimbursement for services provided are driving healthcare organizations to seek innovative value-based, patient-safety focused solutions. Hospitals and ...
On March 20, 2024, the US Food & Drug Administration (FDA) issued a proposed rule titled Drug Products or Categories of Drug Products that Present Demonstrable Difficulties for Compounding Under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback